A detailed history of Hudson Valley Investment Advisors Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Hudson Valley Investment Advisors Inc holds 2,514 shares of NVO stock, worth $357,918. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,514
Holding current value
$357,918
% of portfolio
0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

BUY
$122.71 - $146.91 $308,492 - $369,331
2,514 New
2,514 $358,000
Q4 2023

Jan 12, 2024

BUY
$87.78 - $105.45 $220,678 - $265,101
2,514 New
2,514 $260,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $321B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Hudson Valley Investment Advisors Inc Portfolio

Follow Hudson Valley Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Valley Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Hudson Valley Investment Advisors Inc with notifications on news.